Final ID: Mo2136
Optimizing Outcomes in Atrial Fibrillation - Where Do We Go from Here?
Monday, 11/18/2024 , 01:30PM - 02:30PM
Abstract Poster Session
Khan Muhammad Aslam, Haider Taimoor, Bhattarai Shraddha, Afzal Hafsa, Khan Bilal, Muhammad Anza, Shafique Nouman, Bhatia Hitesh, Aafreen Asna, Adil Abid Nawaz Khan, Akbar Usman, Khan Alamzaib, Haider Muhammad Adnan
A-band titin-truncating variant promotes the development of arrhythmia-induced cardiomyopathy in a novel genetically-engineered porcine modelLee Kwonjae, Del Rio Carlos, Mcnally Elizabeth, Pfenniger Anna, Bhatnagar Ashita, Glinton Kristofor, Burrell Amy, Ober Rebecca, Mcluckie Alicia, Bishop Brian, Rogers Christopher, Geist Gail
Rennison Julie, Smith Jonathan, Chung Mina, Barnard John, Van Wagoner David, Cantlay Catherine, Li Ling, Lovano Beth, Castel Laurie, Cantlay Paul, Gillinov A, Moravec Christine, Willard Belinda
Randomized Controlled Trial of Metformin and Lifestyle/Risk Factor Modification for Upstream Prevention of Atrial Fibrillation Progression: The Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) TrialChung Mina, Cantlay Catherine, Crookshanks Michael, Mchale Megan, Lovano Beth, Castel Laurie, Park Kevin, Foster Parker, Guo Lydia, Yang Lucy, Sullivan Erin, Wass Sojin, Jin Alison, Cantlay Paul, Varma Niraj, Barzilai Benico, Bruemmer Dennis, Cho Leslie, Huang Julie, Hussein Ayman, Kashyap Sangeeta, Xlaffinx Xlukex, Sun Han, Mehra Reena, Moravec Christine, Saliba Walid, Wazni Oussama, Sanders Prashanthan, Nissen Steven, Van Iterson Erik, Smith Jonathan, Van Wagoner David, Barnard John, Kim Hyun Su, Schilling Taylor, Telfer William, Lissemore Frances, Bibidakis Dimitra, Lin Cheryl